Manufacturer of Controlled Substances; Notice of Registration, 8792 [E7-3296]
Download as PDF
<![CDATA[
8792
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 6, 2006, and
published in the Federal Register on
October 18, 2006, (71 FR 61510),
Boehringer Ingelheim Chemicals Inc.,
2820 N. Normandy Drive, Petersburg,
Virginia 23805, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
Drug
Schedule
cprice-sewell on PROD1PC62 with NOTICES
Tetrahydrocannabinols (7370) ....
Amphetamine (1100) ..................
Methylphenidate (1724) ..............
Methadone (9250) ......................
Methadone Intermediate (9254)
Dextropropoxyphene, bulk (nondosage forms) (9273).
Fentanyl(9801) ............................
I
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers for formulation
into finished pharmaceuticals.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Boehringer Ingelheim Chemicals Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Boehringer Ingelheim
Chemicals Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
BILLING CODE 7020–02–P
Dated: February 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–3299 Filed 2–26–07; 8:45 am]
DEPARTMENT OF JUSTICE
By order of the Commission.
Issued: February 21, 2007.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E7–3390 Filed 2–26–07; 8:45 am]
Dated: February 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control Drug Enforcement,
Administration.
[FR Doc. E7–3296 Filed 2–26–07; 8:45 am]
BILLING CODE 4410–09–P
of 1930, as amended (19 U.S.C. 1337),
and in sections 210.45(c), 210.51(a) of
the Commission’s Rules of Practice and
Procedure (19 CFR 210.45(c), 210.51(a)).
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 21, 2006
and published in the Federal Register
on December 1, 2006, (71 FR 69591–
69592), Johnson Matthey, Inc.,
Pharmaceutical Materials, 2003 Nolte
Drive, West Deptford, New Jersey
08066–1742, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in schedule
II:
By Notice dated November 8, 2006
and published in the Federal Register
on November 17, 2006, (71 FR 66974),
Kenco VPI, Division of Kenco Group
Inc., 350 Corporate Place, Chattanooga,
Tennessee 37419, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Nabilone (7379), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for
Drug
Schedule
distribution to its customers.
Phenylacetone (8501) ..................
II
No comments or objections have been
Raw Opium (9600) .......................
II received. DEA has considered the
Concentrate of Poppy Straw
factors in 21 U.S.C. 823(a) and 952(a)
(9670) ........................................
II and determined that the registration of
Kenco VPI to import the basic class of
The company plans to import the
controlled substance is consistent with
listed controlled substances as raw
the public interest and with United
materials for use in the manufacture of
States obligations under international
bulk controlled substances for
treaties, conventions, or protocols in
distribution to its customers.
effect on May 1, 1971, at this time. DEA
No comments or objections have been has investigated Kenco VPI to ensure
that the company’s registration is
received. DEA has considered the
consistent with the public interest. The
factors in 21 U.S.C. 823(a) and 952(a)
investigation has included inspection
and determined that the registration of
Johnson Matthey Inc to import the basic and testing of the company’s physical
classes of controlled substances is
security systems, verification of the
consistent with the public interest and
company’s compliance with state and
with United States obligations under
local laws, and a review of the
international treaties, conventions, or
company’s background and history.
protocols in effect on May 1, 1971, at
Therefore, pursuant to 21 U.S.C. 952(a)
this time. DEA has investigated Johnson and 958(a), and in accordance with 21
Matthey Inc to ensure that the
CFR 1301.34, the above named company
company’s registration is consistent
is granted registration as an importer of
with the public interest. The
the basic class of controlled substance
investigation has included inspection
listed.
and testing of the company’s physical
Dated: February 16, 2007.
security systems, verification of the
Joseph T. Rannazzisi,
company’s compliance with state and
Deputy Assistant Administrator, Office of
local laws, and a review of the
Diversion Control, Drug Enforcement
company’s background and history.
Administration.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21 [FR Doc. E7–3298 Filed 2–26–07; 8:45 am]
CFR 1301.34, the above named company BILLING CODE 4410–09–P
is granted registration as an importer of
the basic classes of controlled
substances listed.
PO 00000
Frm 00115
Fmt 4703
Sfmt 4703
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 72, Number 38 (Tuesday, February 27, 2007)]
[Notices]
[Page 8792]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3296]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 6, 2006, and published in the Federal
Register on October 18, 2006, (71 FR 61510), Boehringer Ingelheim
Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Fentanyl(9801)............................. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers for formulation into finished
pharmaceuticals.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Boehringer Ingelheim Chemicals Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Boehringer Ingelheim Chemicals Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: February 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control Drug
Enforcement, Administration.
[FR Doc. E7-3296 Filed 2-26-07; 8:45 am]
BILLING CODE 4410-09-P
